Back | Next |
home / stock / ctic / ctic message board
Subject | By | Source | When |
---|---|---|---|
what does this mean? | Frankestin | investorshub | 04/16/2023 9:30:52 AM |
what do you make of this data? | Frankestin | investorshub | 04/15/2023 9:20:37 PM |
$CTIC news out | Frankestin | investorshub | 04/12/2023 2:11:16 PM |
Price now | Frankestin | investorshub | 04/11/2023 4:33:46 AM |
$CTIC good read | Frankestin | investorshub | 04/10/2023 7:49:32 AM |
https://clinicaltrials.gov/ct2/show/NCT05531786?cond=pacritinib&draw=2 really s | Frankestin | investorshub | 03/10/2023 3:06:03 PM |
https://investors.ctibiopharma.com/static-files/83278a88-ff8f-457a-bccf-1900fe50 | Frankestin | investorshub | 03/07/2023 8:07:43 AM |
Why did they bring it up early in | Frankestin | investorshub | 03/06/2023 12:28:49 PM |
FDA approval of VONJO (pacritinib) for the treatment | Frankestin | investorshub | 03/06/2023 12:20:22 PM |
https://investors.ctibiopharma.com/static-files/83278a88-ff8f-457a-bccf-1900fe50 | Frankestin | investorshub | 02/07/2023 8:54:53 AM |
Upcoming Events | Frankestin | investorshub | 02/03/2023 8:17:48 AM |
https://clinicaltrials.gov/ct2/show/NCT05657613?cond=pacritinib&draw=2&rank=3 A | Frankestin | investorshub | 01/18/2023 11:07:43 AM |
Net VONJO sales of $32.9M since launch in | Frankestin | investorshub | 01/12/2023 11:55:05 AM |
tomorrow it's Adam Craig's turn with capsule therapy | Frankestin | investorshub | 01/11/2023 9:26:20 PM |
https://clinicaltrials.gov/ct2/show/NCT05657613?cond=pacritinib&draw=2&rank=3 | Frankestin | investorshub | 12/23/2022 12:09:38 PM |
started | Frankestin | investorshub | 12/23/2022 12:08:51 PM |
Stephen Oh, MD, PhD, Associate Professor of Medicine, | Frankestin | investorshub | 12/12/2022 8:56:14 AM |
https://wsw.com/webcast/stifel74/register.aspx?conf=stifel74&page=ctic&url=https | Frankestin | investorshub | 11/15/2022 5:20:09 PM |
https://wsw.com/webcast/jeff255/ctic/1835973 i like Adam Craig | Frankestin | investorshub | 11/15/2022 4:40:57 PM |
whytestocks: $CTIC News Article - CTI BioPharma to Present at Upcoming November Conferences | whytestocks | investorshangout | 11/08/2022 9:15:52 PM |
News, Short Squeeze, Breakout and More Instantly...
CTI BioPharma Announces Cancellation of its 2023 Annual Meeting of Stockholders PR Newswire SEATTLE , May 30, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization ...
Shares of CTI BioPharma Corp. (NASDAQ: CTIC) traded at a new 52-week high today and are currently trading at $8.99. So far today, approximately 1.79M shares have been exchanged, as compared to an average 30-day volume of 10.16M shares. CTI BioPharma Corp., a biopharmaceutical company, focuses...
NEW YORK, NY / ACCESSWIRE / May 16, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Franchise Group, Inc. (NASDAQ: FRG)'s ...